Guangzhou Baiy reported CNY565.01M in Operating Profit for its fiscal quarter ending in September of 2026.





Operating Profit Change Date
Aspen Pharmacare ZAR 3.76B 1.04B Dec/2025
Cipla INR 10.43B 1.55B Sep/2026
Dr.Reddys Laboratories INR 12.16B 8.91B Sep/2026
Jiangsu Hengrui CNY 2.85B 1.17B Sep/2026
Kalbe Farma IDR 977.57B 176.37B Sep/2026
Richter Gedeon HUF 76.16B 13.84B Jun/2026
Sh Fosun Pharma CNY 863.03M 301.08M Sep/2026
Sh Pharmaceutical CNY 2.01B 761.54M Sep/2026
Sun Pharmaceuticals INR 39.07B 3.5B Sep/2026
Teva Pharmaceutical Industries USD 1.19B 954M Sep/2026